載入...
Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?
The availability of disease-modifying drugs for the management of autosomal dominant polycystic kidney disease (ADPKD) has accelerated the need to accurately predict renal prognosis and/or treatment response in this condition. Arginine vasopressin (AVP) is a critical determinant of postnatal kidney...
Na minha lista:
| 發表在: | World J Nephrol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Inc
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5838414/ https://ncbi.nlm.nih.gov/pubmed/29527508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5527/wjn.v7.i2.51 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|